BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36178224)

  • 1. [The role of mercury and arsenic in the etiology and pathogenesis of Parkinson's and Alzheimer's diseases].
    Salkov VN; Voronkov DN; Khudoerkov RM
    Arkh Patol; 2022; 84(5):59-64. PubMed ID: 36178224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of environmental mercury and lead in the etiology of neurodegenerative diseases.
    Monnet-Tschudi F; Zurich MG; Boschat C; Corbaz A; Honegger P
    Rev Environ Health; 2006; 21(2):105-17. PubMed ID: 16898674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of aluminum and lead in the development of Alzheimer's and Parkinson's diseases].
    Salkov VN; Khudoerkov RM
    Arkh Patol; 2021; 83(3):56-61. PubMed ID: 34041898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metals, oxidative stress and neurodegenerative disorders.
    Jomova K; Vondrakova D; Lawson M; Valko M
    Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis.
    Altamura S; Muckenthaler MU
    J Alzheimers Dis; 2009; 16(4):879-95. PubMed ID: 19387120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease.
    Ganguly G; Chakrabarti S; Chatterjee U; Saso L
    Drug Des Devel Ther; 2017; 11():797-810. PubMed ID: 28352155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies.
    Bourdenx M; Koulakiotis NS; Sanoudou D; Bezard E; Dehay B; Tsarbopoulos A
    Prog Neurobiol; 2017 Aug; 155():171-193. PubMed ID: 26209472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New therapeutic strategy for Parkinson's and Alzheimer's disease.
    Esposito E; Cuzzocrea S
    Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship Between Obesity, Alzheimer's Disease, and Parkinson's Disease: an Astrocentric View.
    Martin-Jiménez CA; Gaitán-Vaca DM; Echeverria V; González J; Barreto GE
    Mol Neurobiol; 2017 Nov; 54(9):7096-7115. PubMed ID: 27796748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural Products as the Potential to Improve Alzheimer's and Parkinson's Disease.
    Kim SW; Lee JH; Kim B; Yang G; Kim JU
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shared mechanisms of neurodegeneration in Alzheimer's disease and Parkinson's disease.
    Xie A; Gao J; Xu L; Meng D
    Biomed Res Int; 2014; 2014():648740. PubMed ID: 24900975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Oxidative Stress Mechanisms to Treat Alzheimer's and Parkinson's Disease: A Critical Review.
    Aborode AT; Pustake M; Awuah WA; Alwerdani M; Shah P; Yarlagadda R; Ahmad S; Silva Correia IF; Chandra A; Nansubuga EP; Abdul-Rahman T; Mehta A; Ali O; Amaka SO; Zuñiga YMH; Shkodina AD; Inya OC; Shen B; Alexiou A
    Oxid Med Cell Longev; 2022; 2022():7934442. PubMed ID: 35958022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative Stress and Aging as Risk Factors for Alzheimer's Disease and Parkinson's Disease: The Role of the Antioxidant Melatonin.
    Tchekalarova J; Tzoneva R
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new paradigm for the development of neurodegenerative diseases on the example of Alzheimer's disease and Parkinson's disease.].
    Litvinenko IV; Lobzin VY
    Adv Gerontol; 2022; 35(2):263-273. PubMed ID: 35727933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease.
    Jiang T; Sun Q; Chen S
    Prog Neurobiol; 2016 Dec; 147():1-19. PubMed ID: 27769868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The aging immune system in Alzheimer's and Parkinson's diseases.
    Heavener KS; Bradshaw EM
    Semin Immunopathol; 2022 Sep; 44(5):649-657. PubMed ID: 35505128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Views on the Role of Stress in the Pathogenesis of Chronic Neurodegenerative Diseases.
    Khaspekov LG
    Biochemistry (Mosc); 2021 Jun; 86(6):737-745. PubMed ID: 34225596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
    Peng B; Yang Q; B Joshi R; Liu Y; Akbar M; Song BJ; Zhou S; Wang X
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of zinc and copper ions in the pathogenetic mechanisms of Alzheimer's and Parkinson's diseases.
    Stelmashook EV; Isaev NK; Genrikhs EE; Amelkina GA; Khaspekov LG; Skrebitsky VG; Illarioshkin SN
    Biochemistry (Mosc); 2014 May; 79(5):391-6. PubMed ID: 24954589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common aspects between glaucoma and brain neurodegeneration.
    Saccà SC; Paluan F; Gandolfi S; Manni G; Cutolo CA; Izzotti A
    Mutat Res Rev Mutat Res; 2020; 786():108323. PubMed ID: 33339584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.